Clinical Trial Update: A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector [Phase 1]

View source ↗

Summary

Phase 1 study by Boehringer Ingelheim comparing two formulations of Survodutide administered via different delivery methods in healthy individuals with obesity …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Survodutide (BI456906)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING